Lv11
20 积分 2024-12-30 加入
Severe asthma beyond bronchodilators: Emerging therapeutic approaches
2小时前
待确认
Development of a novel humanized anti-TSLP monoclonal antibody, QX008N, and exploration of combination therapy of anti-TSLP antibody and anti-IL-4R antibody
8天前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
8天前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
8天前
已完结
The Prevalence and Related Factors of Hearing Loss Among Adults: A Systematic Review and Meta-Analyses
15天前
已完结
Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled trial
1个月前
已完结
CXCR2 antagonists for the treatment of pulmonary disease
2个月前
已完结
Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial
2个月前
已完结
Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonist
2个月前
已完结
Efficacy and safety of ZX-7101A, an inhibitor of influenza cap-dependent endonuclease, in adults with uncomplicated influenza: a randomised, double-blind, placebo-controlled phase 2/3 Trial
2个月前
已完结
皖公网安备34019202002308
